Evaluation of the Effects of Less Invasive Stabilization System (LISS) Plating Techniques in Distal Femoral Fractures
Phase 4
Completed
- Conditions
- Femoral Fractures
- Interventions
- Device: LISSDevice: Plates to treat fractures of the distal femur
- Registration Number
- NCT00552331
- Lead Sponsor
- Nova Scotia Health Authority
- Brief Summary
The purpose of this study is to determine whether the rate of fracture healing and fracture union, repaired with the LISS device, will be as good as or better than the usual fracture fixation systems.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
- The patient has read and agree to the consent
- Patient is 16 years or older (bones have finished growing)
- The injury happened in the last 14 days
Exclusion Criteria
- The patient taking part in another study
- The patient has an infection at the operative site
- The patient has a health condition that affects bone healing or interferes with their ability to complete the study requirements (questionnaires, examinations), for example Paget's disease or osteomalacia
- The patient is taking medication that affects bone healing (such as systemic steroids)
- The patient has malignant (tumor) disease
- The patient is unable to attend follow-up clinic visits
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description LISS LISS Treatment of distal femur fracture with less invasive stabilization system Standard Treatment Plates to treat fractures of the distal femur Treatment of distal femoral fractures using locking condylar plates or dynamic condylar screws
- Primary Outcome Measures
Name Time Method Delayed union or nonunion of the distal femur 12 months post operative Determined via radiographic analysis
- Secondary Outcome Measures
Name Time Method Time to clinical healing 12 months assessed by weight-bearing ability and pain
Function as assessed by patient 6 months, 12 months Assessed using LEM, SMFA, and SF-36 questionnaires
Frequency of adverse events 12 months Range of motion Post-op, 6 weeks, 3 months, 6 months, 12 months Gait analysis 12 months
Trial Locations
- Locations (1)
QEII Health Sciences Centre
🇨🇦Halifax, Nova Scotia, Canada